We bring intelligence, experience, connections and smart financial investment to the table.
We invest in cutting-edge companies across Europe that are changing the world.
We are driven by the belief that innovation offers compelling answers to the most pressing problems facing the world – achieving sustainable prosperity.
Connect with ETF Partners.

We'd love to hear from you. Drop us an email, give us a call or follow us on LinkedIn, Medium or Twitter.
ETF Digest

Eagle Genomics opens Indian hub as world interest in microbiome research intensifies

Posted

5 April 2021

Categories

We’re proud to support our portfolio company, Eagle Genomics, as they announce the opening of a new operation in India – within the innovation hub of Laxmi Cyber City in Hyderabad – as the bio revolution continues to transform the global economy.

UK Prime Minister Boris Johnson supported the announcement by stating, “I’m delighted that Eagle Genomics is expanding into India to make the most of the opportunities for UK businesses in one of the world’s biggest economies. Our exporters are brilliant ambassadors for Britain, and I hope today’s announcement is just the start of what you can do for India and the UK.

The buildout of both the engineering and science teams in Hyderabad has already had a significant impact on Eagle Genomics’ growth,” commented Anthony Finbow, Eagle Genomics’ CEO. “We have been able to hire highly skilled, talented engineers in quantities and at a speed that we would not have been able to achieve had we sought to hire in the UK alone. This increased capacity, which will also lead to more hires in the UK to serve the vast Indian opportunity, is already positively impacting the cadence of our platform development, which opens up additional customer verticals and directly leads to growth in terms of customers won and the access to our most proximate addressable markets.

You can read the full announcement HERE.